{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:38:44Z","timestamp":1795149524738,"version":"4.10.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2022JJ40698"],"award-info":[{"award-number":["2022JJ40698"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key R&D Projects in Ningxia Hui Autonomous Region","award":["2022BFH02013"],"award-info":[{"award-number":["2022BFH02013"]}]},{"name":"Chinese medicine research Project of Hunan Province","award":["A2023051"],"award-info":[{"award-number":["A2023051"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    PCSK9, which is closely related to atherosclerosis, is significantly expressed in vascular smooth muscle cells (VSMCs). Moreover, Proprotein Convertase Subtilisin\/Kexin type 9 (PCSK9) mediated phenotypic transformation, abnormal proliferation, and migration of VSMCs play key roles in accelerating atherosclerosis. In this study, by utilizing the significant advantages of nano-materials, a biomimetic nanoliposome loading with Evolocumab (Evol), a PCSK9 inhibitor, was designed to alleviate atherosclerosis. In vitro results showed that (Lipo\u2009+\u2009M)@E NPs up-regulated the levels of \u03b1-SMA and Vimentin, while inhibiting the expression of OPN, which finally result in the inhibition of the phenotypic transition, excessive proliferation, and migration of VSMCs. In addition, the long circulation, excellent targeting, and accumulation performance of (Lipo\u2009+\u2009M)@E NPs significantly decreased the expression of PCSK9 in serum and VSMCs within the\u00a0plaque of ApoE\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice.\n                  <\/jats:p>","DOI":"10.1186\/s12951-023-01904-4","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T13:01:40Z","timestamp":1684501300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Evolocumab loaded Bio-Liposomes for efficient atherosclerosis therapy"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhenxian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhe","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"1904_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","volume":"118","author":"MR Bennett","year":"2016","unstructured":"Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. 2016;118:692\u2013702.","journal-title":"Circ Res"},{"key":"1904_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cellsig.2018.08.019","volume":"52","author":"A Frismantiene","year":"2018","unstructured":"Frismantiene A, Philippova M, Erne P, Resink TJ. Smooth muscle cell-driven vascular diseases and molecular mechanisms of VSMC plasticity. Cell Signal. 2018;52:48\u201364.","journal-title":"Cell Signal"},{"key":"1904_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/apha.12466","volume":"214","author":"DA Chistiakov","year":"2015","unstructured":"Chistiakov DA, Orekhov AN, Bobryshev YV. Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxf). 2015;214:33\u201350.","journal-title":"Acta Physiol (Oxf)"},{"key":"1904_CR4","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41591-019-0512-5","volume":"25","author":"RC Wirka","year":"2019","unstructured":"Wirka RC, Wagh D, Paik DT, Pjanic M, Nguyen T, Miller CL, et al. Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. Nat Med. 2019;25:1280\u20139.","journal-title":"Nat Med"},{"key":"1904_CR5","doi-asserted-by":"publisher","first-page":"8057","DOI":"10.1080\/21655979.2021.1982304","volume":"12","author":"J Ji","year":"2021","unstructured":"Ji J, Feng M, Niu X, Zhang X, Wang Y. Liraglutide blocks the proliferation, migration and phenotypic switching of Homocysteine (Hcy)-induced vascular smooth muscle cells (VSMCs) by suppressing proprotein convertase subtilisin kexin9 (PCSK9)\/low-density lipoprotein receptor (LDLR). Bioengineered. 2021;12:8057\u201366.","journal-title":"Bioengineered"},{"key":"1904_CR6","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1161\/STROKEAHA.120.028567","volume":"51","author":"MJ Alberts","year":"2020","unstructured":"Alberts MJ, Thompson PD. PCSK9 (proprotein convertase subtilisin-kexin type 9) inhibition and stroke prevention: another step forward. Stroke. 2020;51:1361\u20132.","journal-title":"Stroke"},{"key":"1904_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201900036","volume":"8","author":"A Maruf","year":"2019","unstructured":"Maruf A, Wang Y, Yin T, Huang J, Wang N, Durkan C, et al. Atherosclerosis treatment with stimuli-responsive nanoagents: recent advances and future perspectives. Adv Healthc Mater. 2019;8: e1900036.","journal-title":"Adv Healthc Mater"},{"key":"1904_CR8","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.ejmech.2018.08.080","volume":"157","author":"AE Nadimi","year":"2018","unstructured":"Nadimi AE, Ebrahimipour SY, Afshar EG, Falahati-Pour SK, Ahmadi Z, Mohammadinejad R, et al. Nano-scale drug delivery systems for antiarrhythmic agents. Eur J Med Chem. 2018;157:1153\u201363.","journal-title":"Eur J Med Chem"},{"key":"1904_CR9","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1073\/pnas.1015623108","volume":"108","author":"T Harel-Adar","year":"2011","unstructured":"Harel-Adar T, Ben Mordechai T, Amsalem Y, Feinberg MS, Leor J, Cohen S. Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proc Natl Acad Sci USA. 2011;108:1827\u201332.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1904_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/138920012798356934","volume":"13","author":"P Milla","year":"2012","unstructured":"Milla P, Dosio F, Cattel L. PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery. Curr Drug Metab. 2012;13:105\u201319.","journal-title":"Curr Drug Metab"},{"key":"1904_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1021\/acsnano.6b08244","volume":"11","author":"TJ Anchordoquy","year":"2017","unstructured":"Anchordoquy TJ, Barenholz Y, Boraschi D, Chorny M, Decuzzi P, Dobrovolskaia MA, et al. Mechanisms and barriers in cancer nanomedicine: addressing challenges, Looking for Solutions. ACS Nano. 2017;11:12\u20138.","journal-title":"ACS Nano"},{"key":"1904_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202001808","volume":"32","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Krishnan N, Zhou J, Chekuri S, Wei X, Kroll AV, et al. Engineered cell-membrane-coated nanoparticles directly present tumor antigens to promote anticancer immunity. Adv Mater. 2020;32: e2001808.","journal-title":"Adv Mater"},{"key":"1904_CR13","doi-asserted-by":"publisher","first-page":"8131754","DOI":"10.1155\/2020\/8131754","volume":"2020","author":"R Peng","year":"2020","unstructured":"Peng R, Ji H, Jin L, Lin S, Huang Y, Xu K, et al. Macrophage-based therapies for atherosclerosis management. J Immunol Res. 2020;2020:8131754.","journal-title":"J Immunol Res"},{"key":"1904_CR14","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1080\/21691401.2019.1646265","volume":"47","author":"F ZareKazemabadi","year":"2019","unstructured":"ZareKazemabadi F, Heydarinasab A, Akbarzadeh A, Ardjmand M. Preparation, characterization and in vitro evaluation of PEGylated nanoliposomal containing etoposide on lung cancer. Artif Cells Nanomed Biotechnol. 2019;47:3222\u201330.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"1904_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.811616","volume":"12","author":"X Huo","year":"2021","unstructured":"Huo X, Wang Z, Xiao X, Yang C, Su J. Oral administration of nanopeptide CMCS-20H conspicuously boosts immunity and precautionary effect against bacterial infection in fish. Front Immunol. 2021;12: 811616.","journal-title":"Front Immunol"},{"key":"1904_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119301","volume":"217","author":"B Liu","year":"2019","unstructured":"Liu B, Wang W, Fan J, Long Y, Xiao F, Daniyal M, et al. RBC membrane camouflaged prussian blue nanoparticles for gamabutolin loading and combined chemo\/photothermal therapy of breast cancer. Biomaterials. 2019;217: 119301.","journal-title":"Biomaterials"},{"key":"1904_CR17","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jconrel.2021.12.021","volume":"341","author":"H Zhou","year":"2022","unstructured":"Zhou H, You P, Liu H, Fan J, Tong C, Yang A, et al. Artemisinin and Procyanidins loaded multifunctional nanocomplexes alleviate atherosclerosis via simultaneously modulating lipid influx and cholesterol efflux. J Control Release. 2022;341:828\u201343.","journal-title":"J Control Release"},{"key":"1904_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jconrel.2021.09.034","volume":"339","author":"C Xiao","year":"2021","unstructured":"Xiao C, Tong C, Fan J, Wang Z, Xie Q, Long Y, et al. Biomimetic nanoparticles loading with gamabutolin-indomethacin for chemo\/photothermal therapy of cervical cancer and anti-inflammation. J Control Release. 2021;339:259\u201373.","journal-title":"J Control Release"},{"key":"1904_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12951-021-01119-5","volume":"19","author":"B Liu","year":"2021","unstructured":"Liu B, Yan W, Luo L, Wu S, Wang Y, Zhong Y, et al. Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia. J Nanobiotechnol. 2021;19:374.","journal-title":"J Nanobiotechnol"},{"key":"1904_CR20","doi-asserted-by":"publisher","first-page":"8072","DOI":"10.4049\/jimmunol.177.11.8072","volume":"177","author":"JL Gregory","year":"2006","unstructured":"Gregory JL, Morand EF, McKeown SJ, Ralph JA, Hall P, Yang YH, et al. Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2. J Immunol. 2006;177:8072\u20139.","journal-title":"J Immunol"},{"key":"1904_CR21","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.4049\/jimmunol.0902154","volume":"185","author":"R Hart","year":"2010","unstructured":"Hart R, Greaves DR. Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. J Immunol. 2010;185:3728\u201339.","journal-title":"J Immunol"},{"key":"1904_CR22","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1172\/JCI114111","volume":"83","author":"CW Smith","year":"1989","unstructured":"Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest. 1989;83:2008\u201317.","journal-title":"J Clin Invest"},{"key":"1904_CR23","doi-asserted-by":"publisher","first-page":"1910566","DOI":"10.1002\/adfm.201910566","volume":"30","author":"W He","year":"2020","unstructured":"He W, Xing X, Wang X, Wu D, Mitragotri S. Nanocarrier mediated cytosolic delivery of biopharmaceuticals. Adv Func Mater. 2020;30:1910566.","journal-title":"Adv Func Mater"},{"key":"1904_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1039\/C3NR05444F","volume":"6","author":"CM Hu","year":"2014","unstructured":"Hu CM, Fang RH, Luk BT, Zhang L. Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies. Nanoscale. 2014;6:65\u201375.","journal-title":"Nanoscale"},{"key":"1904_CR25","doi-asserted-by":"publisher","first-page":"1900251","DOI":"10.1002\/advs.201900251","volume":"6","author":"Y Han","year":"2019","unstructured":"Han Y, Pan H, Li W, Chen Z, Ma A, Yin T, et al. T cell membrane mimicking nanoparticles with bioorthogonal targeting and immune recognition for enhanced photothermal therapy. Adv Sci (Weinh). 2019;6:1900251.","journal-title":"Adv Sci (Weinh)"},{"key":"1904_CR26","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1039\/D1TB00029B","volume":"9","author":"Y Long","year":"2021","unstructured":"Long Y, Wang Z, Fan J, Yuan L, Tong C, Zhao Y, et al. A hybrid membrane coating nanodrug system against gastric cancer via the VEGFR2\/STAT3 signaling pathway. J Mater Chem B. 2021;9:3838\u201355.","journal-title":"J Mater Chem B"},{"key":"1904_CR27","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1039\/D0BM02211J","volume":"9","author":"Q Xie","year":"2021","unstructured":"Xie Q, Liu Y, Long Y, Wang Z, Jiang S, Ahmed R, et al. Hybrid-cell membrane-coated nanocomplex-loaded chikusetsusaponin IVa methyl ester for a combinational therapy against breast cancer assisted by Ce6. Biomater Sci. 2021;9:2991\u20133004.","journal-title":"Biomater Sci"},{"key":"1904_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1021\/acs.nanolett.8b03439","volume":"19","author":"R Li","year":"2019","unstructured":"Li R, He Y, Zhu Y, Jiang L, Zhang S, Qin J, et al. Route to rheumatoid arthritis by macrophage-derived microvesicle-coated nanoparticles. Nano Lett. 2019;19:124\u201334.","journal-title":"Nano Lett"},{"key":"1904_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.trsl.2015.10.004","volume":"173","author":"N Ferri","year":"2016","unstructured":"Ferri N, Corsini A, Macchi C, Magni P, Ruscica M. Proprotein convertase subtilisin kexin type 9 and high-density lipoprotein metabolism: experimental animal models and clinical evidence. Transl Res. 2016;173:19\u201329.","journal-title":"Transl Res"},{"key":"1904_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tiv.2016.03.010","volume":"34","author":"KR Paudel","year":"2016","unstructured":"Paudel KR, Karki R, Kim DW. Cepharanthine inhibits in vitro VSMC proliferation and migration and vascular inflammatory responses mediated by RAW264.7. Toxicol In Vitro. 2016;34:16\u201325.","journal-title":"Toxicol In Vitro."},{"key":"1904_CR31","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jacbts.2018.08.010","volume":"3","author":"M Zhang","year":"2018","unstructured":"Zhang M, Urabe G, Little C, Wang B, Kent AM, Huang Y, et al. HDAC6 regulates the MRTF-A\/SRF axis and vascular smooth muscle cell plasticity. JACC Basic Transl Sci. 2018;3:782\u201395.","journal-title":"JACC Basic Transl Sci"},{"key":"1904_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2121-8-1","volume":"8","author":"X Liu","year":"2007","unstructured":"Liu X, Luo F, Pan K, Wu W, Chen H. High glucose upregulates connective tissue growth factor expression in human vascular smooth muscle cells. BMC Cell Biol. 2007;8:1.","journal-title":"BMC Cell Biol"},{"key":"1904_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrc3003","volume":"11","author":"A N\u00fcrnberg","year":"2011","unstructured":"N\u00fcrnberg A, Kitzing T, Grosse R. Nucleating actin for invasion. Nat Rev Cancer. 2011;11:177\u201387.","journal-title":"Nat Rev Cancer"},{"key":"1904_CR34","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ceb.2010.08.020","volume":"22","author":"V Sanz-Moreno","year":"2010","unstructured":"Sanz-Moreno V, Marshall CJ. The plasticity of cytoskeletal dynamics underlying neoplastic cell migration. Curr Opin Cell Biol. 2010;22:690\u20136.","journal-title":"Curr Opin Cell Biol"},{"key":"1904_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cardiores.2007.02.012","volume":"74","author":"R Khan","year":"2007","unstructured":"Khan R, Agrotis A, Bobik A. Understanding the role of transforming growth factor-beta1 in intimal thickening after vascular injury. Cardiovasc Res. 2007;74:223\u201334.","journal-title":"Cardiovasc Res"},{"key":"1904_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/MOL.0000000000000279","volume":"27","author":"JA Dubland","year":"2016","unstructured":"Dubland JA, Francis GA. So much cholesterol: the unrecognized importance of smooth muscle cells in atherosclerotic foam cell formation. Curr Opin Lipidol. 2016;27:155\u201361.","journal-title":"Curr Opin Lipidol"},{"key":"1904_CR37","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.113.005015","volume":"129","author":"S Allahverdian","year":"2014","unstructured":"Allahverdian S, Chehroudi AC, McManus BM, Abraham T, Francis GA. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. Circulation. 2014;129:1551\u20139.","journal-title":"Circulation"},{"key":"1904_CR38","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12951-022-01720-2","volume":"20","author":"X Sha","year":"2022","unstructured":"Sha X, Dai Y, Chong L, Wei M, Xing M, Zhang C, et al. Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect. J Nanobiotechnol. 2022;20:506.","journal-title":"J Nanobiotechnol"},{"key":"1904_CR39","doi-asserted-by":"publisher","first-page":"6536","DOI":"10.1021\/acsnano.8b00553","volume":"12","author":"H Liang","year":"2018","unstructured":"Liang H, Huang K, Su T, Li Z, Hu S, Dinh PU, et al. Mesenchymal stem cell\/red blood cell-inspired nanoparticle therapy in mice with carbon tetrachloride-induced acute liver failure. ACS Nano. 2018;12:6536\u201344.","journal-title":"ACS Nano"},{"key":"1904_CR40","first-page":"389","volume":"16","author":"M B\u00e4ck","year":"2019","unstructured":"B\u00e4ck M, Yurdagul A Jr, Tabas I, \u00d6\u00f6rni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 2019;16:389\u2013406.","journal-title":"Nat Rev Cardiol"},{"key":"1904_CR41","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","volume":"73","author":"S Xu","year":"2021","unstructured":"Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021;73:924\u201367.","journal-title":"Pharmacol Rev"},{"key":"1904_CR42","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/cvr\/cvy010","volume":"114","author":"AL Durham","year":"2018","unstructured":"Durham AL, Speer MY, Scatena M, Giachelli CM, Shanahan CM. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness. Cardiovasc Res. 2018;114:590\u2013600.","journal-title":"Cardiovasc Res"},{"key":"1904_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1161\/CIRCRESAHA.114.302355","volume":"114","author":"C Silvestre-Roig","year":"2014","unstructured":"Silvestre-Roig C, de Winther MP, Weber C, Daemen MJ, Lutgens E, Soehnlein O. Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies. Circ Res. 2014;114:214\u201326.","journal-title":"Circ Res"},{"key":"1904_CR44","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.metabol.2015.01.007","volume":"64","author":"I Drosos","year":"2015","unstructured":"Drosos I, Tavridou A, Kolios G. New aspects on the metabolic role of intestinal microbiota in the development of atherosclerosis. Metabolism. 2015;64:476\u201381.","journal-title":"Metabolism"},{"key":"1904_CR45","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.atherosclerosis.2015.05.035","volume":"241","author":"E Org","year":"2015","unstructured":"Org E, Mehrabian M, Lusis AJ. Unraveling the environmental and genetic interactions in atherosclerosis: central role of the gut microbiota. Atherosclerosis. 2015;241:387\u201399.","journal-title":"Atherosclerosis"},{"key":"1904_CR46","doi-asserted-by":"publisher","first-page":"908","DOI":"10.5551\/jat.32672","volume":"23","author":"T Emoto","year":"2016","unstructured":"Emoto T, Yamashita T, Sasaki N, Hirota Y, Hayashi T, So A, et al. Analysis of gut microbiota in coronary artery disease patients: a possible link between gut microbiota and coronary artery disease. J Atheroscler Thromb. 2016;23:908\u201321.","journal-title":"J Atheroscler Thromb"},{"key":"1904_CR47","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.3389\/fmicb.2017.02146","volume":"8","author":"M Lyu","year":"2017","unstructured":"Lyu M, Wang YF, Fan GW, Wang XY, Xu SY, Zhu Y. Balancing herbal medicine and functional food for prevention and treatment of cardiometabolic diseases through modulating gut microbiota. Front Microbiol. 2017;8:2146.","journal-title":"Front Microbiol"},{"key":"1904_CR48","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.dld.2018.03.016","volume":"50","author":"G Gibiino","year":"2018","unstructured":"Gibiino G, Lopetuso LR, Scaldaferri F, Rizzatti G, Binda C, Gasbarrini A. Exploring bacteroidetes: metabolic key points and immunological tricks of our gut commensals. Dig Liver Dis. 2018;50:635\u20139.","journal-title":"Dig Liver Dis"},{"key":"1904_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.585066","volume":"11","author":"H Mu","year":"2020","unstructured":"Mu H, Zhou Q, Yang R, Zeng J, Li X, Zhang R, et al. Naringin attenuates high fat diet induced non-alcoholic fatty liver disease and gut bacterial dysbiosis in mice. Front Microbiol. 2020;11: 585066.","journal-title":"Front Microbiol"},{"key":"1904_CR50","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.1039\/D0FO00439A","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Gao Y, Ma F, Sun M, Mu G, Tuo Y. The ameliorative effect of Lactobacillus plantarum Y44 oral administration on inflammation and lipid metabolism in obese mice fed with a high fat diet. Food Funct. 2020;11:5024\u201339.","journal-title":"Food Funct"},{"key":"1904_CR51","doi-asserted-by":"publisher","first-page":"747","DOI":"10.5551\/jat.RV17036","volume":"26","author":"M Iida","year":"2019","unstructured":"Iida M, Harada S, Takebayashi T. Application of metabolomics to epidemiological studies of atherosclerosis and cardiovascular disease. J Atheroscler Thromb. 2019;26:747\u201357.","journal-title":"J Atheroscler Thromb"},{"key":"1904_CR52","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12944-019-1041-4","volume":"18","author":"LE Simental-Mend\u00eda","year":"2019","unstructured":"Simental-Mend\u00eda LE, Simental-Mend\u00eda M, S\u00e1nchez-Garc\u00eda A, Banach M, Serban MC, Cicero AFG, et al. Impact of ursodeoxycholic acid on circulating lipid concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. Lipids Health Dis. 2019;18:88.","journal-title":"Lipids Health Dis"},{"key":"1904_CR53","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.phrs.2017.06.014","volume":"123","author":"E Gugliandolo","year":"2017","unstructured":"Gugliandolo E, Fusco R, Biundo F, D\u2019Amico R, Benedetto F, Di Paola R, et al. Palmitoylethanolamide and Polydatin combination reduces inflammation and oxidative stress in vascular injury. Pharmacol Res. 2017;123:83\u201392.","journal-title":"Pharmacol Res"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01904-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-01904-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01904-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T14:04:31Z","timestamp":1684505071000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-01904-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1904"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-01904-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,19]]},"assertion":[{"value":"24 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Permission must be obtained from the Animal Ethics Committee of Hunan University before starting any animal experiments. All experiments were conducted in accordance with the guidelines of Hunan University Animal Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}